CAS 257879-35-9

PKCβ Inhibitor

CAS: 257879-35-9

Formula: C₂₄H₂₁N₅O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 411.4558

Ref: IN-DA01G83B

PKCβ inhibitor 1

CAS: 257879-35-9

PKCβ inhibitor 1

Purity: ≥98%

Molecular weight: 411.46g/mol

Ref: 54-BUP04701

PKCβ inhibitor 1

CAS: 257879-35-9

PKCβ inhibitor 1 (KUN79359)(KUN79359) is a potent, selective and ATP-competitive inhibitor of PKC isozymes(IC50s of 21 and 5 nM for human PKCβ1 and PKCβ2,

Formula: C₂₄H₂₁N₅O₂

Purity: 99.33%

Color and Shape: Solid

Molecular weight: 411.46

Ref: TM-T8376

3-(1-(3-IMIDAZOL-1-YLPROPYL)-1H-INDOL-3-YL)-4-ANILINO-1H-PYRROLE-2,5-DIONE

CAS: 257879-35-9

Purity: 98%

Molecular weight: 411.4649963

Ref: 10-F844432

3-Anilino-4-[1-(3-imidazol-1-ylpropyl)indol-3-yl]pyrrole-2,5-dione

Controlled Product

CAS: 257879-35-9

Formula: C₂₄H₂₁N₅O₂

Color and Shape: Neat

Molecular weight: 411.456

Ref: TR-A433470

PKC² inhibitor 1

CAS: 257879-35-9

PKC2 inhibitor 1 is a small molecule that inhibits the PKC2 signaling pathway. It has been shown to reduce the severity of diabetic neuropathy in mice by inhibiting cell death and neuronal degeneration. PKC2 inhibitor 1 also decreased atherosclerotic lesion formation in a pharmacological model of an experimental mouse. This drug can be used to treat congestive heart failure, locomotor activity, and autoimmune diseases such as type I diabetes mellitus.

Formula: C₂₄H₂₁N₅O₂

Purity: Min. 95%

Molecular weight: 411.46 g/mol

Ref: 3D-HKA87935